Positive Results for Mainstay Medical’s Clinical Trial of ReActiv8®

on 31/08/2015 11:34
Clinically important, statistically significant, and lasting improvement in pain, disability, and quality of life for people with Chronic Low Back Pain and limited treatment options.
Read more

Mainstay Medical Announces Half Year Financial Results

on 31/08/2015 11:30

Mainstay Medical Announces Additional US Patent Issued

on 26/08/2015 11:26

Nexstim: Key Technology Patent Granted for US

on 11/08/2015 15:52
Strengthened patent estate around Nexstim’s cutting-edge technology
Read more

New biotech company Confo Therapeutics launched by VIB and Vrije Universiteit Brussel: Capricorn Venture Partners leads 1st financing round of € 3 million

on 24/06/2015 11:11